---
title: "Expected entry into Phase 3 after consultation with FDA — DecisionGateway"
description: "Expected entry into Phase 3 after consultation with FDA"
canonical_url: "https://dgw.tmarket.io/events/01a1d950-daf2-7846-b515-731e3d369306"
meta:
  "og:description": "Expected entry into Phase 3 after consultation with FDA"
  "og:image": "https://dgw.tmarket.io/og.jpg"
  "og:image:alt": "White network of connected nodes crossed by a timeline on black"
  "og:image:height": "1024"
  "og:image:width": "1024"
  "og:title": "Expected entry into Phase 3 after consultation with FDA — DecisionGateway"
  "twitter:image": "https://dgw.tmarket.io/og.jpg"
---

> Index of every page on this site: [llms.txt](https://dgw.tmarket.io/llms.txt)

**Event**/Clinical trial

**Scheduled**

# **Expected entry into Phase 3 after consultation with FDA**

## **Actors and targets**

[fdaparticipant](https://dgw.tmarket.io/actors/01a1c467-14b9-7091-a859-4927cb1c35f1)

[**fda dossier **](https://dgw.tmarket.io/actors/01a1c467-14b9-7091-a859-4927cb1c35f1)

## **Source**

> 추후 FDA와의 협의를 통해 빠르게 임상 3상에 진입할 것으로 전망

*hmsecresearch · Telegram [ Open post](https://t.me/hmsecresearch/6167)*

## **Related events**

Same kind only, ranked by embedding similarity to this record.

```json
{"@context":"https://schema.org","@graph":[{"@id":"https://dgw.tmarket.io/#website","@type":"WebSite","description":"Decisions, events and falsifiable forecasts from 4,000+ Telegram channels — every claim cited. Read free.","name":"DecisionGateway","url":"https://dgw.tmarket.io/","publisher":{"@id":"https://dgw.tmarket.io/#identity"}},{"@id":"https://dgw.tmarket.io/events/01a1d950-daf2-7846-b515-731e3d369306#webpage","@type":"WebPage","description":"Expected entry into Phase 3 after consultation with FDA","name":"Expected entry into Phase 3 after consultation with FDA — DecisionGateway","url":"https://dgw.tmarket.io/events/01a1d950-daf2-7846-b515-731e3d369306","breadcrumb":{"@id":"https://dgw.tmarket.io/events/01a1d950-daf2-7846-b515-731e3d369306#breadcrumb"},"isPartOf":{"@id":"https://dgw.tmarket.io/#website"},"potentialAction":[{"@type":"ReadAction","target":["https://dgw.tmarket.io/events/01a1d950-daf2-7846-b515-731e3d369306"]}]},{"@id":"https://dgw.tmarket.io/#identity","@type":"Organization","name":"DecisionGateway","url":"https://dgw.tmarket.io"},{"@id":"https://dgw.tmarket.io/events/01a1d950-daf2-7846-b515-731e3d369306#breadcrumb","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","name":"Home","item":"https://dgw.tmarket.io","position":1},{"@type":"ListItem","name":"Feed","item":"https://dgw.tmarket.io/feed","position":2},{"@type":"ListItem","name":"Expected entry into Phase 3 after consultation with FDA","position":3}]}]}
```

## Sitemap

See the full [sitemap](https://dgw.tmarket.io/sitemap.md) for all pages.